-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematologic Malignancies

PhD Trainee
Program: Scientific Workshops @ ASH
Wednesday, December 2, 2020: 7:45 AM-8:25 AM
Moderator:
Disclosures:
No relevant conflicts of interest to declare.
Poor Treatment Outcomes of Young (<60 Years) African American Patients Diagnosed with Acute Myeloid Leukemia

Ann-Kathrin Eisfeld, MD

Division of Hematology, The Ohio State University, Columbus, OH
Live Q&A

Ann-Kathrin Eisfeld, MD

Division of Hematology, The Ohio State University, Columbus, OH
Tracing the Evolution of Myeloid Malignancies Using Single Cell Sequencing

Peter van Galen, PhD

Division of Hematology, Brigham and Women's Hospital, Boston, MA
Live Q&A

Peter van Galen, PhD

Massachusets General Hospital, Boston, MA
Mechanisms of Ring Sideroblast Formation in SF3B1-Mutant Myelodysplastic Syndrome

Sergei Doulatov, PhD

University of Washington, Seattle, WA
Live Q&A

Sergei Doulatov, PhD

University of Washington, Seattle, WA
Single-Cell Multi-Omics in Human Clonal Hematopoiesis Reveals That DNMT3A R882 Mutations Perturb Early Progenitor States through Selective Hypomethylation

Anna S Nam, MD

Weill Cornell Medicine, New York, NY
Live Q&A

Anna S Nam, MD

Weill Cornell Medicine, New York, NY
See more of: Scientific Workshops @ ASH
<< Previous Session | Next Session >>